• OPEN AN ACCOUNT
Indian Indices
Nifty
24,716.60 -34.10
(-0.14%)
Sensex
81,113.18 -260.57
( -0.32%)
Bank Nifty
55,903.40 153.70
( 0.28%)
Nifty IT
37,061.85 -259.90
( -0.70%)
Global Indices
Nasdaq
42,330.65 39.58
(0.09%)
Dow Jones
5,956.64 23.95
(0.40%)
Hang Seng
37,492.16 -472.94
(-1.25%)
Nikkei 225
8,774.26 1.88
(0.02%)
Forex
USD-INR
85.54 0.04
(0.05%)
EUR-INR
97.07 0.05
(0.06%)
GBP-INR
115.07 -0.11
(-0.10%)
JPY-INR
0.59 0.00
(-0.04%)

EQUITY - MARKET SCREENER

Acutaas Chemicals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
543349
INE00FF01025
160.2066363
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ACUTAAS
57.64
9197.97
EPS(TTM)
Face Value()
Div & Yield %
19.49
5
0.13
 

India Cements Capital Ltd - Board Meeting Intimation for Approval Of Audited Annual Accounts For 2024-25 And Publication Of Audited Financial Results For The Quarter And Year Ended 31.03.2025
Apr 10,2025
India Cements Capital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/04/2025 inter alia to consider and approve audited annual accounts for the year ended 31st March 2025 (both standalone and consolidated) and standalone and consolidated audited financial results for the quarter and year ended 31st March 2025. The Audit Committee of our Board will review the said financial results and accounts at a meeting to be held earlier to the Board meeting on the same day.